KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) Invested Capital (2016 - 2025)

Historic Invested Capital for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $123.0 billion.

  • Johnson & Johnson's Invested Capital rose 1837.71% to $123.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $123.0 billion, marking a year-over-year increase of 1837.71%. This contributed to the annual value of $123.0 billion for FY2025, which is 1837.71% up from last year.
  • According to the latest figures from Q4 2025, Johnson & Johnson's Invested Capital is $123.0 billion, which was up 1837.71% from $85.7 billion recorded in Q3 2025.
  • Johnson & Johnson's Invested Capital's 5-year high stood at $123.0 billion during Q4 2025, with a 5-year trough of $69.2 billion in Q2 2021.
  • In the last 5 years, Johnson & Johnson's Invested Capital had a median value of $85.7 billion in 2025 and averaged $87.7 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first tumbled by 1156.81% in 2024, then skyrocketed by 1837.71% in 2025.
  • Johnson & Johnson's Invested Capital (Quarter) stood at $74.1 billion in 2021, then grew by 6.69% to $79.0 billion in 2022, then increased by 21.64% to $96.1 billion in 2023, then rose by 8.08% to $103.9 billion in 2024, then increased by 18.38% to $123.0 billion in 2025.
  • Its last three reported values are $123.0 billion in Q4 2025, $85.7 billion for Q3 2025, and $90.0 billion during Q2 2025.